Literature DB >> 8534759

Overproduction of inhibitory hematopoietic cytokines by lipopolysaccharide-activated peripheral blood mononuclear cells in patients with aplastic anemia.

H C Hsu1, W H Tsai, L Y Chen, M L Hsu, C H Ho, C K Lin, S Y Wang.   

Abstract

The aim of this study was to measure the level of cytokines produced by peripheral blood mononuclear cells (PBMNC) in patients with aplastic anemia (AA) and to determine their effect on the clonal growth of normal bone marrow (BM) cells. Twenty-one patients with AA and 11 normal controls were enrolled in this study. Medium conditioned by PBMNC of AA patients in the presence of lipopolysaccharide (LPS) was found to be suppressive to the colony growth of normal BM cells. Thus, we further determined the presence in the PBMNC-conditioned medium (CM) of both inhibitory cytokines: macrophage inflammatory protein-1 alpha (MIP-1 alpha), tumor necrosis factor-alpha (TNF-alpha), transforming growth factor-beta 2 (TGF-beta 2), and interferon-gamma (IFN-gamma), and stimulatory cytokines: interleukin-3 (IL-3) and stem cell factor (SCF). Spontaneous production of MIP-1 alpha was higher in the AA patients than the normal controls (1887 +/- 174 pg/ml vs 1643 +/- 93 pg/ml), but the difference was not significant. After LPS stimulation, the production of MIP-1 alpha was markedly increased in the AA patients, and its level was significantly higher than that of the normal controls (2360 +/- 149 pg/ml vs 1517 +/- 92 pg/ml, p = 0.0022). The level of TNF alpha was also higher in the AA patients. However, IFN-gamma, TGF-beta 2, SCF, and IL-3 were not detectable in the PBMNC-CM of either AA patients or normals. The myelopoietic suppressing effect of AA-PBMNC-CM from each AA patient was significantly blocked by pretreatment with anti-TNF-alpha, resulting in a colony-forming enhancement of 174% +/- 12%. A similar effect was noted in six of 11 AA patients by pretreatment with anti-MIP-1 alpha. We conclude that TNF alpha and MIP-1 alpha can be overproduced by the PBMNC of some AA patients, which may play a role in the progression of AA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8534759     DOI: 10.1007/bf01697980

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  40 in total

1.  Post-hepatitic aplastic anaemia in children in Taiwan, a hepatitis prevalent area.

Authors:  D C Liang; K H Lin; D T Lin; C P Yang; K L Hung; K S Lin
Journal:  Br J Haematol       Date:  1990-04       Impact factor: 6.998

2.  Human bone marrow colony growth in agar-gel.

Authors:  B L Pike; W A Robinson
Journal:  J Cell Physiol       Date:  1970-08       Impact factor: 6.384

3.  T-lymphocyte subpopulations in the peripheral blood and bone marrow of patients with aplastic anemia.

Authors:  R P Falcão; J C Voltarelli; C Bottura
Journal:  Blut       Date:  1985-02

4.  Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.

Authors:  N C Zoumbos; P Gascon; J Y Djeu; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Suppression of in vitro granulocyte-macrophage colony formation by the peripheral mononuclear phagocytic cells of patients with idiopathic aplastic anaemia.

Authors:  T Suda; H Mizoguchi; Y Miura; K Kubota; F Takaku
Journal:  Br J Haematol       Date:  1981-03       Impact factor: 6.998

6.  Lymphocyte phenotype and lymphokines following anti-thymocyte globulin therapy in patients with aplastic anaemia.

Authors:  L Platanias; P Gascon; L Bielory; P Griffith; A Nienhuis; N Young
Journal:  Br J Haematol       Date:  1987-08       Impact factor: 6.998

7.  Release of colony-stimulating activity by resting and activated monocytes, T cells and B cells.

Authors:  L Y Chen; S Y Wang; C K Lin; C H Yung; C S Lee
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1989-05

8.  Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages.

Authors:  J Bauer; U Ganter; T Geiger; U Jacobshagen; T Hirano; T Matsuda; T Kishimoto; T Andus; G Acs; W Gerok
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

9.  Further evidence for lymphokine overproduction in severe aplastic anemia.

Authors:  W Hinterberger; G Adolf; G Aichinger; R Dudczak; K Geissler; P Höcker; C Huber; P Kalhs; W Knapp; U Köller
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

10.  The effect of lipopolysaccharide on the production of GM-EA, GM-CSA, and PGE2 by human monocyte-derived lipid-containing macrophages.

Authors:  S Y Wang; C K Ho; L Y Chen; C K Lin; C H Yung; K Y Chien
Journal:  Exp Hematol       Date:  1988-06       Impact factor: 3.084

View more
  2 in total

1.  Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy.

Authors:  H Joachim Deeg; Margaret O'Donnell; Jakub Tolar; Rajni Agarwal; Richard E Harris; Stephen A Feig; Mary C Territo; Robert H Collins; Peter A McSweeney; Edward A Copelan; Shakila P Khan; Ann Woolfrey; Barry Storer
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

2.  Proliferation and apoptosis of bone marrow CD4(+) T cells in patients with aplastic anemia and impacts of the secreted cytokines on hematopoietic stem cells from umbilical cord blood.

Authors:  Miao Zheng; Hanying Sun; Jianfeng Zhou; Huizhen Xu; Lifang Huang; Wenli Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.